Bernhardt L. Trout

Scientific Advisor at QurAlis

Dr. Bernhardt L. Trout served as Advisor of Continuus Pharmaceuticals, Inc. Bernhard serves as Co-chair of the Singapore-MIT Alliance Program on Chemical and Pharmaceutical Engineering and serves as Director of the Novartis-MIT Center for Continuous Manufacturing and of Continuus Pharmaceuticals, Inc. Bernhardt serves as a Member of Scientific Advisory Board of CMD Bioscience LLC. His research focuses on molecular engineering, specifically the development and application of both computational and experimental molecular-based methods to engineering pharmaceutical formulations and processes with unprecedented specificity. Since 1999, he has focused on molecular engineering for biopharmaceutical formulation, primarily liquid formulation, but also lyophilized formulation. A major aspect of his research focuses on developing both microscopic and macroscopic models to design stable formulations efficiently. He is a Professor of Chemical Engineering at MIT. Bernhardt received a Master’s degree from MIT and his Ph.D. from the University of California at Berkeley.


Org chart

This person is not in the org chart


Teams


Offices

This person is not in any offices


QurAlis

1 followers

QurAlis is developing precision therapeutics for ALS, a terminal disease that causes muscle paralysis through degeneration of the motor system. They are digging deep into the root causes of the multiple sub-forms of this destructive disease and focus their programs on tackling specific disease-causing mechanisms.


Industries

Employees

11-50

Links